Back to results
US 2017/0319547 A1Published application
Anesthetic comprising tetracaine and a vasoconstrictor for administration to a subject
AssigneeSt. Renatus, LLC
InventorMark D. Kollar
Life of this patent
Estimating the term…
Abstract
The present invention relates to tetracaine based anesthetic formulations and methods of use thereof The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.
Claims42
1-20. (canceled)
A pharmaceutical composition comprising:
- 2.5-3.5% (w/v) tetracaine, or a pharmaceutically acceptable salt thereof;
- a vasoconstrictor;
- and
- a pharmaceutically acceptable carrier, wherein said pharmaceutical composition has a pH of about 4.0-7.5.
1 more element
The pharmaceutical composition according to claim 2 4, wherein said oxymetazoline is oxymetazoline salt.
Dependencies are inferred from the claim text.